Medical Director Clinical Science
Beijing Avistone Biotechnology Co., Ltd. · Takeda · Takeda (Note: This product was divested to Mistrau Bio, Inc. in 2026)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Medical Director Clinical Science as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:26 UTC. Showing 200 of 212. Open this list on ClinicalTrials.gov
- Ph1NCT06307795 · A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid TumorsAvistone Biotechnology Co., Ltd. · recruiting · Locally Advanced or Metastatic Solid Tumors · study director
- Ph2NCT04576208 · A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788Takeda · withdrawn · Non-Small Cell Lung Cancer (NSCLC) · study director
- Ph1/Ph2NCT04260009 · Pharmacokinetics, Safety, and Efficacy of Brigatinib Monotherapy in Pediatric and Young Adult Participants With ALK+ Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors or Other Solid TumorsTakeda · withdrawn · Anaplastic Lymphoma Kinase Positive (ALK +) Anaplastic Large Cell Lymphoma, Inflammatory Myofibroblastic Tumors, Solid Tumors · study director
- Ph2NCT03738475 · Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac DiseaseTakeda · completed · Celiac Disease · study director
- Ph2NCT03694275 · A Multicenter, Open-label, Pilot Study of Soticlestat (TAK-935/OV935) in Participants With 15Q Duplication Syndrome (Dup 15q) or Cyclin-Dependent Kinase-Like 5 (CDKL5) Deficiency Disorder (ARCADE STUDY)Takeda · completed · 15q Duplication Syndrome, CDKL5 Deficiency Disease · study director
- Ph2NCT03650452 · A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic EncephalopathiesTakeda · completed · Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome · study director
- Ph3NCT03525119 · Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus VaccineTakeda · completed · Healthy Volunteers · study director
- Ph3NCT03469349 · Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIBTakeda · completed · Peripheral Arterial Diseases · study director
- Ph3NCT03423173 · Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for DengueTakeda · completed · Dengue Fever · study director
- N/ANCT03409796 · Assessment of Immune Activation and Tolerance in Celiac Disease During Gluten ChallengeTakeda · completed · Celiac Disease · study director
- Ph3NCT03342898 · Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Administered With a Yellow Fever Vaccine in AdultsTakeda · completed · Dengue · study director
- Ph3NCT03341637 · Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) in Adolescents in Non-Endemic Area(s)Takeda · completed · Dengue · study director
- Ph2NCT03319953 · A Randomized, Double-Blind, Placebo Controlled, Two-Period Cross-Over, Proof of Activity Study to Evaluate the Effects of TAK-041 on Motivational Anhedonia as Add-On to Antipsychotics in Participants With Stable SchizophreniaNeurocrine Biosciences · completed · Stable Schizophrenia · study director
- Ph2NCT03281577 · Effect of TAK-954 on Gastrointestinal and Colonic Transit in Diabetic or Idiopathic Gastroparesis ParticipantsTakeda · completed · Diabetic Gastroparesis, Idiopathic Gastroparesis · study director
- Ph3NCT03221036 · Efficacy and Safety of Vedolizumab IV in Chinese Participants With Ulcerative ColitisTakeda · active not recruiting · Moderately to Severely Active Ulcerative Colitis · study director
- Ph2NCT03123393 · TAK-659 in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)Calithera Biosciences, Inc · terminated · Diffuse Large B-cell Lymphoma · study director
- Ph1/Ph2NCT03092791 · IPV-102 Safety, Tolerability and Immunogenicity of TAK-195 in Healthy Infants, Toddlers and AdultsTakeda · terminated · Poliomyelitis · study director
- N/ANCT03067506 · Cognitive and Mood Assessment Data in Major Depressive Disorder Using Digital Wearable TechnologyTakeda · completed · Major Depressive Disorder · study director
- Ph3NCT03050359 · Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori InfectionTakeda · completed · Duodenal Ulcer · study director
- Ph4NCT03042325 · Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes MellitusTakeda · withdrawn · Diabetes Mellitus, Type 2 · study director
- Ph3NCT03035058 · Efficacy and Safety of Vedolizumab Intravenous (IV) in the Treatment of Primary Sclerosing Cholangitis in Subjects With Underlying Inflammatory Bowel DiseaseTakeda · withdrawn · Primary Sclerosing Cholangitis, Inflammatory Bowel Disease · study director
- Ph4NCT03029143 · Vedolizumab Intravenous (IV) Dose Optimization in Ulcerative ColitisTakeda · completed · Colitis, Ulcerative · study director
- N/ANCT02993926 · A Study to Assess the Safety and Efficacy of Enantone (Leuprorelin) in Central Precocious Puberty (CPP) Among Chinese ParticipantsTakeda · completed · Central Precocious Puberty · study director
- N/ANCT02989649 · Non-Interventional Study of the Use of Alogliptin and Alogliptin Fixed-Dose Combinations With Pioglitazone and With Metformin in Standard Clinical PracticeTakeda · terminated · Diabetes Mellitus, Type 2 · study director
- Ph4NCT02972632 · Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive DisorderTakeda · completed · Major Depressive Disorder · study director
- Ph3NCT02969265 · An Efficacy and Safety Study Evaluating the Fixed-Dose Combination of Candesartan Plus Amlodipine in Participants With Mild/Moderate Essential HypertensionTakeda · withdrawn · Hypertension · study director
- Ph2NCT02948829 · Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy ChildrenTakeda · completed · Healthy Volunteers · study director
- Ph2NCT02939014 · Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL)Takeda · completed · Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic · study director
- Ph4NCT02932904 · Effect of Vortioxetine, Paroxetine, and Placebo on Sexual Functioning in Healthy VolunteersTakeda · completed · Healthy Volunteers · study director
- Ph2NCT02913508 · Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's DiseaseTakeda · withdrawn · Ulcerative Colitis, Crohn's Disease · study director
- N/ANCT02899884 · Characterisation and Epidemiology of Breakthrough Cancer Pain in SpainTakeda · completed · Breakthrough Cancer Pain · study director
- Ph1NCT02834247 · A Study of TAK-659 in Combination With Nivolumab in Participants With Advanced Solid TumorsCalithera Biosciences, Inc · terminated · Triple-Negative Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Carcinoma, Squamous Cell · study director
- Ph3NCT02814565 · Cyclobenzaprine HCl Extended Release 15 mg Versus Placebo in Treatment of Cervical and/or Lower Back Pain Due to Muscle Spasms of Local OriginTakeda · completed · Neck Pain, Back Pain, Spasm · study director
- N/ANCT02788916 · A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell LymphomasTakeda · completed · Lymphoma, T-Cell, Peripheral · study director
- Ph1NCT02774902 · TAK-438_110 Drug Interaction With Cytochrome P450 3A4 (CYP3A4) Inhibitor ClarithromycinTakeda · completed · Healthy Volunteers · study director
- Ph1NCT02769065 · Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy ParticipantsTakeda · terminated · Alzheimer Disease, Healthy Volunteers · study director
- Ph4NCT02760615 · Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction StudyTakeda · withdrawn · Colitis, Ulcerative, Crohn Disease · study director
- N/A
- N/ANCT02756832 · An Observational Study of Alogliptin Benzoate in Participants With Diabetes Mellitus Type 2Takeda · completed · Diabetes Mellitus · study director
- Ph1NCT02748694 · Phase 1 TAK-041 First-in-Human Safety, Tolerability, and Pharmacokinetics StudyNeurocrine Biosciences · completed · Healthy Volunteers, Schizophrenia · study director
- Ph2NCT02743949 · Comparison of Vonoprazan to Esomeprazole in Participants With Symptomatic GERD Who Responded Partially to a High Dose of Proton Pump Inhibitor (PPI)Takeda · completed · Gastroesophageal Reflux · study director
- Ph3NCT02729909 · Lubiprostone for Chronic Idiopathic Constipation TreatmentTakeda · completed · Constipation · study director
- Ph2NCT02725268 · A Study of Sapanisertib, Combination of Sapanisertib With MLN1117, Paclitaxel and Combination of Sapanisertib With Paclitaxel in Women With Endometrial CancerMillennium Pharmaceuticals, Inc. · completed · Endometrial Neoplasms · study director
- Ph3NCT02695719 · Lubiprostone for Treatment of Chronic Idiopathic ConstipationTakeda · completed · Chronic Idiopathic Constipation · study director
- Ph1NCT02684396 · Phase 1, TAK-648, Single-Rising Dose StudyTakeda · completed · Healthy Volunteers · study director
- Ph2NCT02661490 · Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine in an Elderly PopulationTakeda · completed · Norovirus · study director
- Ph3NCT02651155 · Lubiprostone for the Treatment of Chronic Idiopathic ConstipationTakeda · completed · Constipation · study director
- Ph4NCT02638129 · Naltrexone/Bupropion Cardiovascular Outcomes StudyOrexigen Therapeutics, Inc · terminated · Obesity, Cardiovascular Diseases · study director
- Ph4NCT02630966 · Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's DiseaseTakeda · completed · Crohn's Disease · study director
- Ph3NCT02629848 · Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung CancerTakeda · terminated · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT02620046 · A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's DiseaseTakeda · completed · Colitis, Ulcerative, Crohn's Disease · study director
- Ph3NCT02611817 · Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease (CD)Takeda · completed · Crohn's Disease · study director
- Ph3NCT02611830 · Efficacy and Safety of Vedolizumab Subcutaneously (SC) as Maintenance Therapy in Ulcerative ColitisTakeda · completed · Colitis, Ulcerative · study director
- Ph1NCT02584569 · Phase 1 TAK-915 Single-Dose Positron Emission Tomography (PET) Occupancy StudyTakeda · completed · Healthy Volunteers · study director
- Ph1NCT02528786 · Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) StudyTakeda · completed · Rheumatoid Arthritis · study director
- Ph4NCT02517866 · Azilsartan Medoxomil in the Treatment of Essential Hypertension and Type 2 Diabetes in AsiaTakeda · completed · Essential Hypertension, Type 2 Diabetes Mellitus · study director
- Ph1NCT02508168 · Phase 1 Bioavailability Study of SYR-322METTakeda · completed · Healthy Volunteers · study director
- Ph1NCT02504320 · Phase 1, Febuxostat XR Relative Bioavailability StudyTakeda · completed · Healthy Volunteers · study director
- Ph3NCT02480764 · Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionTakeda · completed · Essential Hypertension · study director
- Ph2NCT02475278 · Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle VaccineTakeda · completed · Norovirus, Healthy Participants · study director
- N/ANCT02467855 · Epidemiological Study in Thai Participants With HypertensionTakeda · completed · Hypertension · study director
- Ph1NCT02461160 · Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants StudyTakeda · completed · Healthy Volunteers · study director
- Ph4NCT02457247 · Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.Takeda · completed · Calcium and Vitamin D Deficiencies · study director
- Ph1NCT02442752 · Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 MonthsTakeda · withdrawn · Pediatric Gastroesophageal Reflux Disease · study director
- Ph2NCT02425098 · Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in SingaporeTakeda · completed · Dengue Fever · study director
- Ph3NCT02425111 · Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's DiseaseTakeda · completed · Crohn's Disease · study director
- Ph1NCT02412722 · A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic MalignanciesMillennium Pharmaceuticals, Inc. · completed · Non-hematologic Malignancy · study director
- Ph1NCT02413255 · Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy VolunteersTakeda · completed · Healthy Volunteers · study director
- Ph2NCT02410499 · Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With MacroalbuminuriaTakeda · withdrawn · Diabetic Nephropathy · study director
- Ph1NCT02396147 · Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy ParticipantsTakeda · completed · Healthy Volunteers · study director
- Ph1/Ph2NCT02393209 · Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung CancerMillennium Pharmaceuticals, Inc. · terminated · Non-small Cell Lung Cancer · study director
- Ph1NCT02391038 · MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase CMillennium Pharmaceuticals, Inc. · terminated · Advanced Gastrointestinal Carcinoma, Gastroesophageal Junction Adenocarcinoma, Recurrent Gastric Adenocarcinoma · study director
- Ph1NCT02389881 · Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy ParticipantsTakeda · completed · Healthy Volunteers · study director
- Ph3NCT02388737 · Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive EsophagitisTakeda · completed · Erosive Esophagitis · study director
- Ph3NCT02388724 · Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive EsophagitisTakeda · completed · Erosive Esophagitis · study director
- Ph2NCT02388971 · Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular DiseaseTakeda · withdrawn · Atherosclerotic Cardiovascular Disease · study director
- Ph1NCT02382640 · Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release CapsuleTakeda · completed · Healthy Volunteers · study director
- Ph2NCT02381288 · Effects of TAK-448 in Middle-aged and Older Men With Low TestosteroneTakeda · terminated · Low Testosterone · study director
- Ph2NCT02379091 · Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)Takeda · completed · Rheumatoid Arthritis · study director
- Ph1NCT02374164 · Food Effect Study of Febuxostat XR in Healthy ParticipantsTakeda · completed · Gout · study director
- Ph4NCT02371980 · Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)Takeda · completed · Major Depressive Disorder · study director
- Ph1NCT02370602 · An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063Takeda · completed · Healthy Volunteers · study director
- Ph2NCT02369796 · A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic HypogonadismTakeda · terminated · Hypogonadotropic Hypogonadism · study director
- Ph1NCT02367352 · Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsMillennium Pharmaceuticals, Inc. · terminated · Advanced Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer · study director
- Ph1NCT02338713 · Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium AbsorptionTakeda · completed · Healthy Volunteers · study director
- Ph1NCT02334982 · Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy ParticipantsTakeda · completed · Dose Finding Study · study director
- Ph2NCT02332824 · A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaTakeda · completed · Type 2 Diabetes Mellitus and Microalbuminuria · study director
- Ph1NCT02327169 · A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesMillennium Pharmaceuticals, Inc. · completed · Advanced Nonhematologic Malignancies · study director
- Ph3NCT02302092 · An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract InfectionsTakeda · terminated · Urinary Tract Infection · study director
- Ph4NCT02287402 · Postmarketing Clinical Study on AO-128Takeda · completed · Impaired Glucose Tolerance (IGT) · study director
- Ph3NCT02284906 · AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseTakeda · terminated · Mild Cognitive Impairment Due to Alzheimer's Disease · study director
- Ph3NCT02277691 · A Phase III Long-term Study of TAK-536TCH in Participants With Essential HypertensionTakeda · completed · Essential Hypertension · study director
- Ph1NCT02252354 · TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability StudyTakeda · completed · Healthy Volunteers · study director
- Ph1NCT02219256 · A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy ParticipantsTakeda · completed · Autoimmune Disease · study director
- Ph1NCT02214147 · Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic FunctionMillennium Pharmaceuticals, Inc. · completed · Advanced Solid Tumors, Relapsed/Refractory Lymphoma · study director
- Ph1NCT02209506 · Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese ParticipantsTakeda · terminated · Safety, Tolerability, Pharmacokinetics · study director
- Ph3NCT02203916 · Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionTakeda · completed · Hypertension · study director
- Ph2NCT02202785 · A Study of MLN0264 in Patients With Pancreatic CancerMillennium Pharmaceuticals, Inc. · terminated · Pancreatic Adenocarcinoma · study director
- Ph2NCT02202759 · A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal JunctionMillennium Pharmaceuticals, Inc. · terminated · Adenocarcinoma of the Stomach, Gastroesophageal Junction Expressing Guanylyl Cyclase C · study director
- Ph1NCT02201056 · Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935Takeda · completed · Healthy Volunteers · study director
- Ph1NCT02197572 · Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid TumorsCalithera Biosciences, Inc · completed · Advanced Solid Tumors · study director
- Ph2NCT02193087 · Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)Takeda · completed · Dengue Fever · study director
- Ph1NCT02176486 · Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)Takeda · terminated · Lupus Nephritis · study director
- Ph1NCT02170220 · Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic ImpairmentTakeda · completed · Severe Hepatic Impairment · study director
- Ph1NCT02163915 · Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.Takeda · terminated · Attention-Deficit/Hyperactivity Disorder · study director
- Ph2NCT02162758 · Effect of Dexlansoprazole 60 mg QD and 60 mg BID on Recurrence of Intestinal Metaplasia in Subjects Who Have Achieved Complete Eradication of Barrett's Esophagus With Radiofrequency AblationTakeda · terminated · Barrett's Esophagus · study director
- Ph1NCT02163421 · Bioavailability and Pharmacokinetics of Vedolizumab in Healthy Participants Following Single Subcutaneous AdministrationTakeda · completed · Healthy · study director
- Ph1NCT02153099 · Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of ENV8058 (TAK-058) in Healthy ParticipantsTakeda · completed · Dose Finding Study · study director
- Ph2NCT02153112 · Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in ChildrenTakeda · completed · Norovirus · study director
- Ph2NCT02142504 · Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy AdultsTakeda · completed · Norovirus Prevention · study director
- Ph1NCT02141711 · TAK-438 - Safety, Blood Levels & Effects of Repeated DosesTakeda · completed · Erosive Esophagitis(EE), Gastroesophageal Reflux Disease (GERD) · study director
- Ph1NCT02141698 · Safety, Tolerability, and Pharmacokinetics of TAK-438 in Healthy Western Male Subjects, Preliminary Food Effect Analysis, and an Ethnic Comparison With Japanese SubjectsTakeda · completed · Dose Finding Study · study director
- Ph3NCT02139046 · Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With GoutTakeda · completed · Gout · study director
- Ph2NCT02129777 · Efficacy and Safety of Namilumab (MT203) for Plaque PsoriasisTakeda · completed · Plaque Psoriasis · study director
- Ph2NCT02128490 · Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal ImpairmentTakeda · completed · Gout, Moderate Renal Impairment · study director
- Ph1NCT02123953 · Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-438 in Healthy Male ParticipantsTakeda · completed · Dose Finding Study · study director
- Ph1NCT02123927 · Safety, Tolerability and Pharmacokinetics of TAK-438 in Healthy Male ParticipantsTakeda · completed · Ascending Single Dose Study · study director
- Ph1NCT02122770 · Effects of Fluconazole and Itraconazole CYP3A-Mediated Inhibition on the Pharmacokinetics, Safety, and Tolerability of MLN4924 in Participants With Advanced Solid TumorsMillennium Pharmaceuticals, Inc. · completed · Advanced Solid Tumors · study director
- Ph1NCT02096458 · Sensory Evaluation of Dexlansoprazole Delayed-Release Orally Disintegrating TabletsTakeda · completed · Gastroesophageal Reflux Disease, Erosive Esophagitis, Heartburn · study director
- Ph2NCT02094573 · A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With CrizotinibAriad Pharmaceuticals · completed · Carcinoma, Non-Small-Cell Lung · study director
- Ph3NCT02085252 · A Study of the Effect of Enantone LP 11.25 mg (Leuprorelin) on the Histological Progression of Indolent Prostate CancerTakeda · completed · Prostate Cancer · study director
- Ph1NCT02079844 · Roflumilast Plus Antipsychotics Proof of Mechanism Study in SchizophreniaTakeda · completed · Schizophrenia · study director
- Ph1NCT02064907 · Bioavailability, Safety, and Pharmacodynamics of Dexlansoprazole Delayed-Release Orally Disintegrating Tablets in Healthy ParticipantsTakeda · completed · Bioavailability · study director
- Ph2/Ph3NCT02063854 · A Phase II/III, Double-blind, Parallel Group Comparative Study of Oral Administration of NE-58095 TabletsTakeda · completed · Involutional Osteoporosis · study director
- Ph4NCT02049814 · Efficacy and Safety of Voglibose Compared With Acarbose in Participants With Type 2 DiabetesTakeda · completed · Type 2 Diabetes Mellitus · study director
- Ph2NCT02038907 · Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent VLP VaccineTakeda · completed · Healthy Volunteers, Norovirus, Prevention · study director
- Ph2NCT02038647 · Phase 2 Study of Alisertib (MLN8237) in Combination With Paclitaxel Versus Placebo in Combination With Paclitaxel as Second Line Therapy for Small Cell Lung Cancer (SCLC)Millennium Pharmaceuticals, Inc. · completed · Small Cell Lung Cancer · study director
- Ph2NCT01982253 · Fasiglifam 25 mg BID vs 50 mg QDTakeda · terminated · Type 2 Diabetes Mellitus · study director
- Ph3NCT01850524 · IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple MyelomaMillennium Pharmaceuticals, Inc. · completed · Multiple Myeloma · study director
- Ph1NCT01765426 · Phase 1b Study Investigating Safety & Immunogenicity of TDV Given Intradermally by Needle or Needle-Free PharmaJet InjectorTakeda · completed · Healthy Volunteers · study director
- Ph3NCT01732692 · Evaluation of the Efficacy, Safety and Tolerance of Experimental Morning-only MOVIPREP® Bowel Preparation in Comparison With Split-dose With Nocturnal Pause MOVIPREP® Bowel PreparationTakeda · completed · Bowel Preparation Prior to Endoscopic, Radiological and Other Examinations as Well as to Surgical Procedures Which Require Empty Bowel. · study director
- Ph1NCT01728792 · Impact of SC vs IM Administration of DENVax (TDV) on Safety and ImmunogenicityTakeda · completed · Dengue Fever · study director
- Ph1NCT01714947 · Mass Balance, Pharmacokinetics and Metabolism Study of AlisertibMillennium Pharmaceuticals, Inc. · completed · Advanced Solid Tumors, Lymphoma · study director
- Ph3NCT01685151 · A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 DisorderTakeda · withdrawn · Bipolar Disorder · study director
- Ph3NCT01677182 · Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 DisorderTakeda · terminated · Bipolar Disorder · study director
- Ph1NCT01645930 · Phase 1 Pharmacokinetic Study of Oral Ixazomib Plus Lenalidomide and Dexamethasone in Adult Asian Participants With Relapsed and/or Refractory Multiple MyelomaMillennium Pharmaceuticals, Inc. · completed · Multiple Myeloma · study director
- Ph2NCT01642602 · Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in AdolescentsTakeda · completed · Gastroesophageal Reflux Disease · study director
- Ph2NCT01642615 · Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in AdolescentsTakeda · completed · Gastroesophageal Reflux Disease, Erosive Esophagitis · study director
- Ph3NCT01609582 · Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular DiseaseTakeda · terminated · Type 2 Diabetes, Cardiovascular Disease · study director
- Ph3NCT01601704 · Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)Orexigen Therapeutics, Inc · terminated · Obesity, Overweight · study director
- Ph2NCT01564862 · Efficacy of Lu AA21004 on Cognitive Dysfunction in Major Depressive DisorderTakeda · completed · Depressive Disorder, Major · study director
- Ph3NCT01549964 · Comparison of Fasiglifam (TAK-875) to Placebo and Sitagliptin in Combination With Metformin in Participants With Type 2 DiabetesTakeda · terminated · Glycemic Control · study director
- Ph2NCT01549977 · Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable AnginaTakeda · terminated · Angina · study director
- Ph3NCT01546623 · A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal TherapyTakeda · completed · Prostate Cancer · study director
- Ph1NCT01512758 · A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or LymphomasMillennium Pharmaceuticals, Inc. · completed · Advanced Solid Tumors, Lymphomas · study director
- Ph2NCT01511250 · Study to Investigate the Safety and Immunogenicity of a Tetravalent Chimeric Dengue Vaccine in Healthy Volunteers Between the Ages of 1.5 - 45 YearsTakeda · completed · Healthy · study director
- Ph3NCT01500135 · Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular SurgeryTakeda · completed · Bleeding · study director
- Ph1NCT01496443 · TAK-875 Glimepiride Drug-Interaction StudyTakeda · completed · Pharmacokinetics · study director
- Ph2NCT01496469 · Effect of Febuxostat on Blood PressureTakeda · completed · Hypertension · study director
- Ph3NCT01478971 · Conversion Study From Epoetin Alfa to Monthly Peginesatide Injection in Patients With Chronic Kidney Disease on DialysisTakeda · completed · Chronic Kidney Disease, Anemia · study director
- Ph2NCT01473758 · Effect of Roflumilast at Acute Exacerbations of Chronic Obstructive Pulmonary DiseaseAstraZeneca · terminated · Chronic Obstructive Pulmonary Disease With (Acute) Exacerbation · study director
- Ph3NCT01467713 · Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I DisorderTakeda · terminated · Bipolar Disorder · study director
- Ph3NCT01467700 · Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I DisorderTakeda · terminated · Acute Depressive Episode · study director
- Ph3NCT01456130 · Long-term Study of Alogliptin as an Add-on to Rapid-Acting Insulin Secretagogues in Type 2 DiabetesTakeda · completed · Diabetes Mellitus · study director
- Ph3NCT01456169 · A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil AloneTakeda · completed · Essential Hypertension · study director
- Ph3NCT01429051 · A Clinical Trial With Intranasal Fentanyl in Cancer Patients With Breakthrough PainTakeda · completed · Break Through Pain, Cancer · study director
- Ph2NCT01414920 · Efficacy and Safety of TAK-875 in Combination With Sitagliptin in Participants With Type 2 Diabetes MellitusTakeda · completed · Diabetes Mellitus, Type 2 · study director
- Ph1NCT01311076 · TAK-329 Glucose Clamp StudyTakeda · completed · Type 1 Diabetes Mellitus · study director
- Ph3
- Ph1NCT01299805 · Effects of Vortioxetine (Lu AA21004) on the Concentrations of Selected Neurotransmitters in Healthy Male AdultsTakeda · completed · Healthy · study director
- Ph2/Ph3NCT01255787 · Efficacy and Safety Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive DisorderTakeda · completed · Depressive Disorder, Major · study director
- Ph1NCT01216293 · Effect of Dexlansoprazole on Bone HomeostasisTakeda · completed · Homeostasis, Bone and Bones · study director
- Ph2NCT01207440 · Ponatinib for Chronic Myeloid Leukemia (CML) Evaluation and Ph+ Acute Lymphoblastic Leukemia (ALL)Ariad Pharmaceuticals · completed · Chronic Myeloid Leukemia, Ph+ Acute Lymphoblastic Leukemia · study director
- Ph3NCT01179516 · Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderTakeda · completed · Depressive Disorder, Major · study director
- Ph3NCT01163266 · Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderTakeda · completed · Depressive Disorder, Major · study director
- Ph3NCT01153009 · Safety and Efficacy of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderTakeda · completed · Depressive Disorder, Major · study director
- Ph2NCT01077284 · Febuxostat Versus Allopurinol or Placebo in Patients With Hyperuricosuria and Calcium Oxalate StonesTakeda · completed · Hyperuricosuria, Kidney Stones · study director
- Ph1NCT01045096 · Study to Evaluate the Pharmacokinetics and Safety of Dexlansoprazole in Pediatric Subjects With Symptomatic Gastroesophageal Reflux DiseaseTakeda · completed · Gastroesophageal Reflux · study director
- Ph2NCT01007097 · Efficacy and Safety of TAK-875 in Subjects With Type 2 Diabetes MellitusTakeda · completed · Diabetes Mellitus, Type 2 · study director
- Ph3NCT00996281 · Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential HypertensionTakeda · completed · Essential Hypertension · study director
- Ph3NCT00968708 · Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary SyndromeTakeda · completed · Diabetes Mellitus, Type 2, Acute Coronary Syndrome · study director
- Ph1NCT00962091 · Study of MLN8237 in Participants With Advanced Solid TumorsMillennium Pharmaceuticals, Inc. · completed · Advanced Solid Tumors · study director
- Ph1NCT00949091 · Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 DiabetesTakeda · completed · Diabetes Mellitus, Type 2 · study director
- Ph1
- Ph3NCT00856284 · Efficacy and Safety of Alogliptin Plus Metformin Compared to Glipizide Plus Metformin in Patients With Type 2 Diabetes MellitusTakeda · completed · Type 2 Diabetes Mellitus · study director
- Ph2NCT00853307 · MLN8237 for Treatment of Participants With Ovarian, Fallopian Tube, or Peritoneal CarcinomaMillennium Pharmaceuticals, Inc. · completed · Ovarian Carcinoma · study director
- Ph3NCT00847808 · Efficacy of Dexlansoprazole MR on Heartburn Control in Participants Previously Receiving Twice Daily Proton Pump Inhibitor TherapyTakeda · completed · Gastroesophageal Reflux · study director
- Ph2NCT00830518 · A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic SyndromeMillennium Pharmaceuticals, Inc. · completed · Acute Myelogenous Leukemia, High-Grade Myelodysplastic Syndrome · study director
- Ph2NCT00807495 · Study of Alisertib (MLN8237) in Adults With Aggressive Non-Hodgkin's LymphomaMillennium Pharmaceuticals, Inc. · completed · Diffuse Large B-cell Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma · study director
- Ph2NCT00760968 · Efficacy and Safety of TAK-783 in Subjects With Rheumatoid ArthritisTakeda · completed · Arthritis, Rheumatoid · study director
- Ph2NCT00756041 · Safety Study of TAK-128 in Subjects With Diabetic Peripheral NeuropathyTakeda · terminated · Diabetic Neuropathies · study director
- Ph3NCT00756002 · Safety and Efficacy Study of Ramelteon in Subjects With Chronic InsomniaTakeda · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph2NCT00755495 · Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic InsomniaTakeda · completed · Sleep Initiation and Maintenance Disorders · study director
- Ph3NCT00744627 · Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.Takeda · completed · Generalized Anxiety Disorder · study director
- Ph3NCT00735709 · Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderTakeda · completed · Major Depressive Disorder · study director
- Ph3NCT00734071 · An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderTakeda · completed · Generalized Anxiety Disorder · study director
- Ph3NCT00731120 · Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderTakeda · completed · Generalized Anxiety Disorder · study director
- Ph3NCT00730691 · Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety DisorderTakeda · completed · Generalized Anxiety Disorder · study director
- Ph2NCT00722917 · Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes MellitusTakeda · terminated · Diabetes Mellitus · study director
- Ph3NCT00722137 · Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell LymphomaMillennium Pharmaceuticals, Inc. · completed · Mantle Cell Lymphoma · study director
- Ph3NCT00707980 · Safety and Tolerability of Vortioxetine (Lu AA21004) in Adults With Major Depressive DisorderTakeda · completed · Major Depressive Disorder · study director
- Ph1NCT00697346 · Study of MLN8237 in Participants With Advanced Hematological MalignanciesMillennium Pharmaceuticals, Inc. · completed · B-cell Follicular Lymphoma, B-cell Marginal Zone Lymphoma, Diffuse Large B-cell Lymphoma · study director
- Ph3NCT00695955 · One-Year Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential HypertensionTakeda · completed · Hypertension · study director
- Ph3NCT00696436 · An Efficacy and Safety Study of Azilsartan Medoxomil Compared to Valsartan and Olmesartan in Participants With Essential Hypertension.Takeda · completed · Hypertension · study director
- Ph2NCT00677053 · Safety and Efficacy of TAK-442 in Subjects With Acute Coronary SyndromesTakeda · completed · Acute Coronary Syndrome · study director
- Ph3NCT00672958 · Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Adults With Major Depressive DisorderTakeda · completed · Major Depressive Disorder · study director
- Ph3NCT00672620 · Efficacy and Safety of Vortioxetine (Lu AA21004) in the Treatment of Patients With Major Depressive DisorderTakeda · completed · Major Depressive Disorder · study director
- Ph1NCT00651664 · A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced MalignanciesMillennium Pharmaceuticals, Inc. · completed · Advanced Malignancies · study director
- Ph2NCT00641732 · Efficacy and Safety of TAK-442 in Subjects Undergoing Total Knee ReplacementTakeda · completed · Venous Thromboembolism · study director
- Ph2NCT00593736 · Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase SyndromeTakeda · completed · Sleep Disorders, Circadian Rhythm · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.